Moleculin Biotech (MBRX) has released an update.
Moleculin Biotech, Inc. recently conducted a virtual investor call led by Chairman and CEO Walter Klemp, offering insights into the company’s progress and future plans. For those interested in the biotech sector’s stock potential, the call provided valuable information, accessible through a publicly available link. While the call’s script was documented, it’s not classified as an official filing under securities laws but serves as an informational resource for investors.
For further insights into MBRX stock, check out TipRanks’ Stock Analysis page.
